Vimarsana
Biggest News Aggregation in the World

Page 19 - Published March News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Published March. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Published March Today - Breaking & Trending Today

Roche introduces navify® Algorithm Suite, a digital library of medical algorithms that enhances clinical decision-making to optimise patient care - Vimarsana News

Roche introduces navify® Algorithm Suite, a digital library of medical algorithms that enhances clinical decision-making to optimise patient care

At the global HIMSS1 Conference, Roche showcases navify Algorithm Suite, a single platform offering clinicians access to medical algorithms generating insights...

Q&A: Maternal health care disparities, distrust disproportionately affect Black women - Vimarsana News

Q&A: Maternal health care disparities, distrust disproportionately affect Black women

A CDC report released in March identified a 40% increase in maternal mortality in the U.S. in 2021 compared with 2020 and a mortality rate 2.6 times higher among Black women compared with white women.

Source: healio.com
Increased Nursing Facility Surveillance Testing Associated with Reduction in COVID-19 Deaths - Vimarsana News

Increased Nursing Facility Surveillance Testing Associated with Reduction in COVID-19 Deaths

New results of a retrospective cohort study showed an important trend with regard to COVID-19 cases and skilled nursing facilities practicing surveillance testing.

Safety, tolerability of pediatric cystic fibrosis dual therapy sustained for 4 years - Vimarsana News

Safety, tolerability of pediatric cystic fibrosis dual therapy sustained for 4 years

Combination therapy with tezacaftor/ivacaftor was safe and well tolerated for up to 216 weeks in children aged 12 years or older, according to results of an extension study published in Journal of Cystic Fibrosis.“Since we are talking about medications that would be taken forever, it is important to know that safety and benefits persist,” Patrick A. Flume, MD, director of the Medical

Source: healio.com
Co-sensitization to different legumes common but often not clinically relevant - Vimarsana News

Co-sensitization to different legumes common but often not clinically relevant

Co-sensitization between legumes in different legume-allergic patients was frequent, but large proportions of these co-sensitizations were not clinically relevant, according to a study published in Frontiers in Allergy. But as legumes become more popular as alternative protein sources, providers should still mind their potential for increased risks for new sensitizations and allergies, Thuy-My

Source: healio.com